CClinicalTrials.gg
RecruitingNCT07017660Updated Jun 15, 2025

Virtual Reality Application During Cystoscopy

An interventional study of virtual reality glasses and No intervention in Virtual Reality and Rigid Cystoscopy, sponsored by Ayten Akkaya. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-06-15.

Sponsored by Ayten Akkaya · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This randomized controlled experimental study aimed to determine the effect of virtual reality glasses during cystoscopy on pain, anxiety and patient satisfaction.

Read the detailed description

Patients in the intervention arm; In order to evaluate pain, anxiety and patient satisfaction regarding the cystoscopy procedure, the patient's pain level will be assessed with the Visual Analog Scale 10 minutes before the procedure and the patient's anxiety level will be assessed with the State Anxiety Scale. Patients will be asked to wear virtual reality glasses starting three minutes before the procedure and until the procedure is completed. The patient will be shown a video of nature scenes with the virtual reality glasses and will also be made to listen to the sounds of water and birds. Routine institution procedures will be applied during the cystoscopy procedure. 10 minutes after the procedure, the patient's pain and satisfaction level will be assessed with the Visual Analog Scale and the patient's anxiety level will be assessed with the State Anxiety Scale.

Patients in the control arm; To assess pain, anxiety, and patient satisfaction with the cystoscopy procedure, the patient's pain level will be assessed with the Visual Analog Scale and the patient's anxiety level will be assessed with the State Anxiety Scale 10 minutes before the procedure. Routine institution procedures will be applied during the cystoscopy procedure. 10 minutes after the procedure, the patient's pain and satisfaction levels will be assessed with the Visual Analog Scale and the patient's anxiety level will be assessed with the State Anxiety Scale.

02

Conditions studied

  • Virtual Reality
  • Rigid Cystoscopy

Keywords

  • Cystoscopy
  • Pain
  • anxiety
  • satisfaction
  • virtual reality
03

In context

Lead sponsor

This is the only study on the registry with Ayten Akkaya as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years of age and older,
  • First elective and rigid cystoscopy performed under local anesthesia,
  • No vision, hearing and perception problems,
  • Open to communication and able to speak Turkish,
  • Patients who agree to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Contraindications for the procedure (lidocaine allergy, urinary tract infection, anatomical problems related to the urethra, etc.)
  • Use of any analgesic or sedative medication at least 4 hours before cystoscopy Patients who undergo manipulation such as J stent placement or removal and/or bladder biopsy.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Other
    control group

    Routine institution procedures will be applied during the cystoscopy procedure.

    Other: No intervention

  • Experimental
    virtual reality glasses

    Patients will be asked to wear virtual reality glasses starting three minutes before the procedure and until the procedure is completed. The patient will be shown a video of nature scenes with the virtual reality glasses and will also be made to listen to the sounds of water and birds. Routine institution procedures will be applied during the cystoscopy procedure.

    Other: virtual reality glasses

Interventions

  • Othervirtual reality glasses

    Patients will be asked to wear virtual reality glasses starting three minutes before the procedure and until it is completed. With the virtual reality glasses, the patient will be shown a video of nature scenes and made to listen to the sounds of water and birds. Routine institutional procedures will be applied during the cystoscopy procedure.

  • OtherNo intervention

    Routine institution procedures will be applied during the cystoscopy procedure.

06

What researchers measure

Primary outcomes

  1. Visual Analog scale

    Rating is done on a scale with a 10 cm horizontal or vertical ruler and "0" means dissatisfaction and "10" means the highest level of satisfaction.

    Time frame: 1 day

  2. Visual Analog Scale

    Grading is made with a 10 cm long horizantal or vertical ruler on the scale and "0" means no pain and "10" means the most severe pain.

    Time frame: 1 day

  3. Spielberg State Anxiety Scale

    The scale has a four-point Likert structure consisting of 20 items, and a total score of 20-80 is obtained.

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Ankara Etlik City Hospital
    Ankara, Turkey
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07017660
Lead sponsor
Ayten Akkaya
Responsible party
Ayten Akkaya (Assist. Prof. Dr., Ankara Medipol University) — Sponsor-investigator
First posted
Jun 12, 2025
Start date
Jun 11, 2025
Primary completion
Aug 2025 (estimated)
Completion
Oct 2025 (estimated)
Last update
Jun 15, 2025

Study contacts

Ayten Akkaya, PhD
Contact
aytenkoc81@gmail.com
+905052931663
Hasan N. G. Göktuğ, PhD
Contact
drgoksel@yahoo.com
+9003127970000
Ayten Akkaya, PhD
principal investigator · Ankara Medipol University Faculty of Health Sciences, Department of Nursing

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion